CD38 and B-cell chronic lymphocytic leukemia: The most clinically significant markers of poor CLL outcome are the lack of mutations in the immunoglobulin heavy chain variable region (IGHV), chromosomal abnormalities, as well as high expression of ZAP-70 (zeta-associated protein 70) and CD38 [19,20,21].